TAZAROTENE

Post-LOE

tazarotene

ANDATOPICALCREAM
Approved
Nov 2025
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
10

Clinical Trials (5)

NCT04720105Phase 4Completed

Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis

Started Nov 2020
NCT04071756Phase 2Terminated

Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions

Started Dec 2019
8 enrolled
Solid TumorHand-Foot Skin Reaction (HFSR)
NCT01119651Phase 1Completed

A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.

Started Jun 2010
59 enrolled
Acne Vulgaris
NCT01115322Phase 1Completed

A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers

Started Apr 2010
38 enrolled
Acne Vulgaris
NCT01114841Phase 1Completed

A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers

Started Mar 2010
254 enrolled
Acne Vulgaris